| Objective: Silencing P2X7 expression by short interfering RNA reduce P2X7 expression in P388D1 cells. It was analyzed whether P2X7 is related to the P388D1 metastasis to peripheral lymph nodes.Methods: Analysis of P2X7 expression by RNA extraction and reverse transcriptase polymerase chain reaction (RT-PCR), Flow Cytometry analysis. Next shRNA knockdown of P388D1 cells P2X7 expression. Experimental metastasis in DBA/2 mice P2X7 shRNA and control shRNAs were transiently transfected with Effectene transfection reagent following the manufacturer's instructions. Effects of down-regulation on P2X7 shRNA at 30h after the transfection was assessed with flow cytometry and RT-PCR and immunofluorescence assay. Inbred strain 24 DBA/2 mice, female and male are the same quantity. Being divided into four experiment groups at random, each group has 6 mice. One group is for P2X7 shRNA, the other is as control shRNA group, the third is blocked P2X7 by polyclonal anti-P2X7 Ab. The last group is negative control according to the group of blocked polyclonal anti-P2X7 Ab by rabbit IgG. Each mouse foot pad injected into cells of 6×105, observed the survival rate and the dissemination condition of tumor cells.Results: RT-PCR, Flow Cytometry analysis and Immunofluorescence assay demonstrated that P2X7 expression on P388D1 murine lymphoid neoplasm cell line. We measured the level of P2X7 receptor expression in with transfection shRNA P388D1 cells by Flow Cytometry, RT-PCR and Immunofluorescence. It was shown that expression of P2X7 by the P388D1 murine lymphoid neoplasm cell line can be silenced by P2X7 shRNA.Conclusion: Base on our study, it is indicated that P2X7 has a potential role for dissemination to peripheral lymph nodes. It will open a new vision for the clinic treatment of tumor. |